A detailed history of International Assets Investment Management, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 12,700 shares of CLSD stock, worth $11,049. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,700
Previous 20,000 36.5%
Holding current value
$11,049
Previous $26 Million 61.54%
% of portfolio
0.03%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$0.93 - $1.35 $6,789 - $9,855
-7,300 Reduced 36.5%
12,700 $10 Million
Q2 2024

Jul 30, 2024

SELL
$1.08 - $1.58 $17,280 - $25,280
-16,000 Reduced 44.44%
20,000 $26 Million
Q1 2024

Apr 11, 2024

BUY
$1.2 - $2.02 $43,200 - $72,720
36,000 New
36,000 $56.9 Million

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $52.4M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.